Charles Schwab’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-74,869
| Closed | -$7.3M | – | 3196 |
|
|
2015
Q1 | $7.3M | Buy |
74,869
+16,952
| +29% | +$1.65M | 0.01% | 1233 |
|
|
2014
Q4 | $5.38M | Buy |
57,917
+250
| +0.4% | +$23.2K | 0.01% | 1393 |
|
|
2014
Q3 | $3.97M | Buy |
57,667
+2,796
| +5% | +$192K | 0.01% | 1561 |
|
|
2014
Q2 | $5.75M | Buy |
54,871
+1,820
| +3% | +$191K | 0.01% | 1281 |
|
|
2014
Q1 | $4.4M | Buy |
53,051
+626
| +1% | +$51.9K | 0.01% | 1434 |
|
|
2013
Q4 | $3.39M | Buy |
52,425
+6,846
| +15% | +$443K | 0.01% | 1566 |
|
|
2013
Q3 | $2.96M | Buy |
45,579
+8,409
| +23% | +$547K | 0.01% | 1582 |
|
|
2013
Q2 | $1.59M | Buy |
+37,170
| New | +$1.59M | ﹤0.01% | 1898 |
|